Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 311% % -16%
Quick Ratio 10% % -21%
Debt-to-equity 153% % 5.8%
Return On Equity -30% % 56%
Return On Assets -12% % 57%
Operating Margin -21% % 77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 153,981,561 shares 1.4%
Common Stock, Shares, Outstanding 153,779,418 shares 4.1%
Entity Public Float $1,385,000,000 USD 233%
Common Stock, Value, Issued $15,000 USD 7.1%
Weighted Average Number of Shares Outstanding, Basic 151,721,939 shares 3.1%
Weighted Average Number of Shares Outstanding, Diluted 151,721,939 shares 3.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $276,976,000 USD 55%
Research and Development Expense $93,769,000 USD -8.9%
Selling and Marketing Expense $94,571,000 USD 12%
General and Administrative Expense $72,701,000 USD -0.14%
Costs and Expenses $334,099,000 USD -2.2%
Operating Income (Loss) $57,123,000 USD 65%
Net Income (Loss) Attributable to Parent $59,499,000 USD 63%
Earnings Per Share, Basic -0.39 USD/shares 64%
Earnings Per Share, Diluted -0.39 USD/shares 64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $70,495,000 USD 47%
Accounts Receivable, after Allowance for Credit Loss, Current $50,365,000 USD 21%
Inventory, Net $9,820,000 USD 16%
Assets, Current $300,185,000 USD 5.8%
Property, Plant and Equipment, Net $34,107,000 USD -30%
Operating Lease, Right-of-Use Asset $40,616,000 USD -11%
Goodwill $118,972,000 USD 0%
Other Assets, Noncurrent $1,207,000 USD -47%
Assets $512,736,000 USD -4.9%
Accounts Payable, Current $6,467,000 USD -11%
Employee-related Liabilities, Current $16,992,000 USD 7.3%
Accrued Liabilities, Current $7,700,000 USD -5.6%
Contract with Customer, Liability, Current $45,194,000 USD -19%
Liabilities, Current $89,915,000 USD -8.3%
Contract with Customer, Liability, Noncurrent $1,006,000 USD -96%
Operating Lease, Liability, Noncurrent $70,228,000 USD -11%
Other Liabilities, Noncurrent $20,000 USD 0%
Liabilities $287,735,000 USD -15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $253,000 USD 52%
Retained Earnings (Accumulated Deficit) $1,363,323,000 USD -4.6%
Stockholders' Equity Attributable to Parent $218,793,000 USD 7.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $225,001,000 USD 11%
Liabilities and Equity $512,736,000 USD -4.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $28,484,000 USD 26%
Net Cash Provided by (Used in) Financing Activities $5,451,000 USD 12289%
Net Cash Provided by (Used in) Investing Activities $25,573,000 USD -43%
Common Stock, Shares Authorized 340,000,000 shares 0%
Common Stock, Shares, Issued 153,779,418 shares 4.1%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,540,000 USD -59%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,373,000 USD 3.7%
Deferred Tax Assets, Valuation Allowance $441,312,000 USD 1.3%
Deferred Tax Assets, Gross $451,297,000 USD 0.94%
Operating Lease, Liability $79,148,000 USD -11%
Depreciation $4,312,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $1,259,000 USD -17%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $59,412,000 USD 63%
Lessee, Operating Lease, Liability, to be Paid $93,518,000 USD -13%
Property, Plant and Equipment, Gross $129,893,000 USD -4.8%
Operating Lease, Liability, Current $8,920,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,944,000 USD -3.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,330,000 USD -13%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14,370,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three $12,282,000 USD 2.8%
Deferred Tax Assets, Operating Loss Carryforwards $286,076,000 USD 4.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $11,716,000 USD 9.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $12,630,000 USD 2.8%
Operating Lease, Payments $3,000,000 USD -19%
Additional Paid in Capital $1,581,848,000 USD 5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,699,000 USD -0.24%
Deferred Tax Assets, Net of Valuation Allowance $9,985,000 USD -14%
Share-based Payment Arrangement, Expense $51,483,000 USD -4%
Interest Expense $11,778,000 USD 1.7%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%